臨床研究等提出・公開システム

Date of registration	May. 06, 2021
Last modified on	May. 06, 2021
Trial ID	jRCT1050210015

Scientific Title	A platform study for developing diagnostic / treatment strategy for COVID-19 patients (COVID-19 platform study)
Public Title	COVID-19 platform study (COVID-19 platform study)

Contact for Scientific Queries	Name	Muto Manabu
	Affiliation	Kyoto Univerisity
	Address	54 Shogoin Kawaharacho Sakyoku Kyoto-shi Kyoto pref.
	Telephone	+81-75-751-4592
	E-mail	mmuto@kuhp.kyoto-u.ac.jp
Contact for Public Queries	Name	Kikuchi Osamu
	Affiliation	Kyoto University Hospital
	Address	54 Shogoin Kawaharacho Sakyoku Kyoto-shi Kyoto pref.
	Telephone	+81-75-366-7646
	E-mail	osamukke@kuhp.kyoto-u.ac.jp

Recruitment status	Recruiting


Anticipated date of first enrollment		Dec. 23, 2020
Target sample size		100
Study Type		Observational
Study Design	allocation	single arm study
	masking	open(masking not used)
	control	uncontrolled control
	assignment	single assignment
	purpose	other
Key inclusion & exclusion criteria	Inclusion Criteria	1) Definite COVID-19 patients 2) Male or female >= 18 years of age 3) Under close observation or in-patient hosptalization 4) Signed written informed consent approved by the relevant Independent Ethics Committee
	Age Minimum	18age old over
	Age Maximum	No limit

Health Condition(s) or Problem(s) Studied		COVID-19
Health Condition(s) Keyword		COVID-19
Health Condition(s) Code		C01.748.214

Secondary Sponsor

Source of Monetary Support	AMED
Secondary Sponsor

Name of Certified Review Board	Kyoto University Graduate School and Faculty of Medicine, Ethics Committee
Address	Yoshiakonoecho Sakyoku Kyoto, Kyoto
Telephone	+81-75-753-4680
E-Mail	ethcom@kuhp.kyoto-u.ac.jp
Approval Status	Approval
Date of approval	Dec. 23, 2020

Plan to share IPD	No

Countries of Recruitment（Except Japan）	none